Initial and midterm results of the Bolton Relay Thoracic Aortic Endovascular Pivotal Trial

Data from the Relay TEVAR clinical trial demonstrate safety and effectiveness of the Relay device compared with surgical controls, indicating continued device durability with a low rate of device-related complications through 5 years.